{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T20:00:09Z","timestamp":1791576009779,"version":"4.3.4"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicon"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.toxicon.2025.108274","type":"journal-article","created":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T06:28:53Z","timestamp":1738823333000},"page":"108274","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["The saga of the development of laboratory tests to evaluate the neutralizing efficacy of antivenoms for the treatment of snakebite envenoming"],"prefix":"10.1016","volume":"256","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8385-3081","authenticated-orcid":false,"given":"Hern\u00e1n","family":"Bonilla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Mar\u00eda","family":"Guti\u00e9rrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.toxicon.2025.108274_bib1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0008579","article-title":"An analysis of preclinical efficacy testing of antivenoms for sub-Saharan Africa: Inadequate independent scrutiny and poor-quality reporting are barriers to improving snakebite treatment and management","volume":"14","author":"Ainsworth","year":"2020","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.toxicon.2025.108274_bib2","first-page":"21","article-title":"Emprego da rea\u00e7\u00e3o de flocula\u00e7\u00e3o espec\u00edfica na dosagem do antivneno crot\u00e1lico","volume":"18","author":"Arantes","year":"1944","journal-title":"Memorias Instituto Butantan"},{"key":"10.1016\/j.toxicon.2025.108274_bib3","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.toxicon.2007.11.002","article-title":"Potency estimation of antivenoms in Brazil: the national control laboratory experience between 2000 and 2006","volume":"51","author":"Araujo","year":"2008","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2025.108274_bib4","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1017\/S0022172400015084","article-title":"Methods of estimating the LD50 in quantal response data","volume":"48","author":"Armitage","year":"1950","journal-title":"J. Hyg."},{"key":"10.1016\/j.toxicon.2025.108274_bib5","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1007\/BF02177838","article-title":"Die titration eines serums gegen schlangengift an m\u00e4usen (Serum antivipera ammodytes)","volume":"120","author":"Bani\u0107","year":"1938","journal-title":"Zeitschr. f. Hygiene."},{"key":"10.1016\/j.toxicon.2025.108274_bib6","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.3390\/toxins6071979","article-title":"Comparative studies of the venom of a new Taipan species, Oxyuranus temporalis, with other members of the genus","volume":"6","author":"Barber","year":"2014","journal-title":"Toxins"},{"key":"10.1016\/j.toxicon.2025.108274_bib7","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1055\/s-0029-1207589","article-title":"Ueber das zustandekommen der diphtherie-immunit\u00e4t und der tetanus- immunit\u00e4t bei thieren","volume":"16","author":"Behring","year":"1890","journal-title":"Dtsch. Med. Wochenschr."},{"key":"10.1016\/j.toxicon.2025.108274_bib8","doi-asserted-by":"crossref","first-page":"360","DOI":"10.4269\/ajtmh.1972.21.360","article-title":"Toxicity of Costa Rican snake venoms for the white mouse","volume":"21","author":"Bola\u00f1os","year":"1972","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.toxicon.2025.108274_bib9","series-title":"Manual de Procedimientos. Producci\u00f3n y Pruebas de Control en la Preparaci\u00f3n de Antisueros Dift\u00e9rico, Tet\u00e1nico, Botul\u00ednico, Antivenenos y de la Gangrena Gaseosa","first-page":"104","article-title":"Antivenenos","author":"Bola\u00f1os","year":"1977"},{"key":"10.1016\/j.toxicon.2025.108274_bib10","series-title":"Envenomings and Their Treatment","first-page":"3","article-title":"Serum therapy was discovered 100 years ago","author":"Bon","year":"1995"},{"key":"10.1016\/j.toxicon.2025.108274_bib11","series-title":"A Defesa Contra O Ophidismo","first-page":"152","author":"Brazil","year":"1911"},{"key":"10.1016\/j.toxicon.2025.108274_bib12","first-page":"457","article-title":"Dosagem do valor anti-toxico dos seruns anti-pe\u00e7onhentos","volume":"10","author":"Brazil","year":"1907","journal-title":"Rev. M\u00e9d. S\u00e3o Paulo"},{"key":"10.1016\/j.toxicon.2025.108274_bib13","article-title":"Soto antibotr\u00f3pico (pentavalente)","volume":"vol. 2","year":"2019"},{"key":"10.1016\/j.toxicon.2025.108274_bib14","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1136\/bmj.2.1859.399","article-title":"The treatment of animals poisoned with snake venom by the injection of antivenomous serum","volume":"2","author":"Calmette","year":"1896","journal-title":"Br. Med. J."},{"key":"10.1016\/j.toxicon.2025.108274_bib15","series-title":"Les Venins, les Animaux Venimeux et la S\u00e9roth\u00e9rapie Antivenimeuse","first-page":"396","author":"Calmette","year":"1907"},{"key":"10.1016\/j.toxicon.2025.108274_bib16","first-page":"155","article-title":"Les pr\u00e9cipitines du s\u00e9rum antivenimeux vis-\u00e0.vis du venin de cobra","volume":"23","author":"Calmette","year":"1909","journal-title":"Ann. Inst. Pasteur."},{"key":"10.1016\/j.toxicon.2025.108274_bib17","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.toxicon.2018.04.015","article-title":"Toxin-resolved antivenomics-guided assessment of the immunorecognition landscape of antivenoms","volume":"148","author":"Calvete","year":"2018","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2025.108274_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.toxicon.2024.108157","article-title":"A simple method to determine proteolytic activity of snake venoms","volume":"251","author":"Camicia","year":"2024","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2025.108274_bib19","first-page":"440","article-title":"Core body temperature as adjunct to endpoint determination in murine median lethal dose testing of rattlesnake venom","volume":"64","author":"Cates","year":"2014","journal-title":"Comp. Med."},{"key":"10.1016\/j.toxicon.2025.108274_bib20","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.toxicon.2014.11.223","article-title":"The lethality test used for estimating the potency of antivenoms against Bothrops asper snake venom: pathophysiological mechanisms, prophylactic analgesia, and a surrogate in vitro assay","volume":"93","author":"Chac\u00f3n","year":"2015","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2025.108274_bib21","series-title":"South African Institute for Medical Research","first-page":"129","article-title":"South African snake venoms and antivenoms","author":"Christensen","year":"1955"},{"key":"10.1016\/j.toxicon.2025.108274_bib22","first-page":"305","article-title":"Venom and antivenom potency estimation","volume":"33","author":"Christensen","year":"1966","journal-title":"Memorias Instituto Butantan"},{"key":"10.1016\/j.toxicon.2025.108274_bib23","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0041-0101(67)90169-9","article-title":"Remarks on antivenin potency estimation","volume":"5","author":"Christensen","year":"1967","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2025.108274_bib24","series-title":"Snake Venoms","first-page":"825","article-title":"Production and standardization of antivenin","author":"Christensen","year":"1979"},{"key":"10.1016\/j.toxicon.2025.108274_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.toxicon.2024.107831","article-title":"Lethality associated with snake venom exposure can be predicted by temperature drop in Swiss mice","volume":"247","author":"De Jes\u00fas","year":"2024","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2025.108274_bib26","article-title":"Assessing a 6-h endpoint observation time in the lethality neutralization assay used to evaluate the preclinical efficacy of snake antivenoms","volume":"12","author":"Dur\u00e1n","year":"2021","journal-title":"Toxicon:X"},{"key":"10.1016\/j.toxicon.2025.108274_bib27","doi-asserted-by":"crossref","first-page":"101","DOI":"10.4049\/jimmunol.57.2.101","article-title":"A dilution-phenomenon in the titration of antivenins (antibothropic sera)","volume":"57","author":"Eichbaum","year":"1947","journal-title":"J. Immunol."},{"key":"10.1016\/j.toxicon.2025.108274_bib28","series-title":"European Pharmacopoeia","first-page":"1238","article-title":"Viper venom antiserum, European","year":"2023"},{"key":"10.1016\/j.toxicon.2025.108274_bib30","first-page":"79","article-title":"Survey of assay methods of antivenins; immunological factors influencing antivenin standardization","volume":"16","author":"Grasset","year":"1957","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.toxicon.2025.108274_bib31","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0035-9203(35)90031-1","article-title":"Studies on the toxic and antigenic properties of southern African snake venoms with special reference to the polyvalency of South African antivenene","volume":"28","author":"Grasset","year":"1935","journal-title":"Trans. Roy. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.toxicon.2025.108274_bib32","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/0161-5890(91)90034-H","article-title":"Discovery of antitoxins and development of antibody preparations for clinical use from 1890 to 1990","volume":"28","author":"Gronski","year":"1991","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.toxicon.2025.108274_bib33","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.toxicon.2018.02.053","article-title":"Preclinical assessment of the neutralizing efficacy of snake antivenoms in Latin America and the Caribbean: a review","volume":"146","author":"Guti\u00e9rrez","year":"2018","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2025.108274_bib34","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/0041-0101(80)90087-2","article-title":"Mionecrosis, hemorragia y edema inducidos por el veneno de Bothrops asper en rat\u00f3n blanco","volume":"18","author":"Guti\u00e9rrez","year":"1980","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2025.108274_bib35","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/0041-0101(81)90007-6","article-title":"Neutralizaci\u00f3n de los efectos locales del veneno de Bothrops asper por un antiveneno polivalente","volume":"19","author":"Guti\u00e9rrez","year":"1981","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2025.108274_bib36","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/0041-0101(85)90380-0","article-title":"Neutralization of proteolytic and hemorrhagic activities of Costa Rican snake venoms by a polyvalent antivenom","volume":"23","author":"Guti\u00e9rrez","year":"1985","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2025.108274_bib37","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jprot.2009.01.008","article-title":"Snake venomics and antivenomics: proteomic tolos in the design and control of antivenoms for the treatment of snakebite envenoming","volume":"72","author":"Guti\u00e9rrez","year":"2009","journal-title":"J. Proteonomics"},{"key":"10.1016\/j.toxicon.2025.108274_bib38","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.jprot.2014.02.021","article-title":"Immunological profile of antivenoms: preclinical analysis of the efficacy of a polyspecific antivenom through antivenomics and neutralization assays","volume":"105","author":"Guti\u00e9rrez","year":"2014","journal-title":"J. Proteonomics"},{"key":"10.1016\/j.toxicon.2025.108274_bib39","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3390\/toxins9050163","article-title":"Preclinical evaluation of the efficacy of antivenoms for snakebite envenoming: state-of-the art and challenges ahead","volume":"9","author":"Guti\u00e9rrez","year":"2017","journal-title":"Toxins"},{"key":"10.1016\/j.toxicon.2025.108274_bib40","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.617429","article-title":"In vitro tests for assessing the neutralizing ability of antivenoms: toward the 3Rs principles","volume":"11","author":"Guti\u00e9rrez","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.toxicon.2025.108274_bib77","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.toxicon.2012.12.008","article-title":"On the use of analgesia in experimental toxinology","volume":"64","author":"Harris","year":"2013","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2025.108274_bib41","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/0041-0101(92)90851-U","article-title":"Pioneers of anti-venomous serotherapy: Dr vital Brazil (1865-1950)","volume":"30","author":"Hawgood","year":"1992","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2025.108274_bib42","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/S0041-0101(99)00086-0","article-title":"Doctor Albert Calmette 1863-1933: founder of antivenomous serotherapy and of antituberculous BCG vaccination","volume":"37","author":"Hawgood","year":"1999","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2025.108274_bib43","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.toxicon.2018.09.012","article-title":"Analgesic effect of morphine and tramadol in standard toxicity assays in mice injected with venom of the snake Bothrops asper","volume":"154","author":"Herrera","year":"2018","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2025.108274_bib44","series-title":"Progress report on the possibility of standardizing anti-snake-venom sera","first-page":"785","author":"Ipsen","year":"1938"},{"key":"10.1016\/j.toxicon.2025.108274_bib45","doi-asserted-by":"crossref","first-page":"528","DOI":"10.3390\/toxins12090528","article-title":"Novel snakebite therapeutics must be tested in appropriate rescue models to robustly assess their preclinical efficacy","volume":"12","author":"Knudsen","year":"2020","journal-title":"Toxins"},{"key":"10.1016\/j.toxicon.2025.108274_bib46","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0041-0101(71)90006-7","article-title":"Toxicity and some enzymatic properties and activities of venoms of Crotalidae, Elapidae and Viperidae","volume":"9","author":"Kocholaty","year":"1971","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2025.108274_bib47","doi-asserted-by":"crossref","first-page":"43","DOI":"10.7883\/yoken1952.13.43","article-title":"Studies on the quantitative method for determination of hemorrhagic activity of Habu snake venom","volume":"13","author":"Kondo","year":"1960","journal-title":"Jpn. J. Med. Sci. Biol."},{"key":"10.1016\/j.toxicon.2025.108274_bib48","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s40409-017-0117-8","article-title":"Strategies of \u2018snake venomics\u2019 aiming at an integrative view of compositional, functional, and immunological characteristics of venoms","volume":"23","author":"Lomonte","year":"2017","journal-title":"J. Venom. Anim. Toxins Incl. Trop. Dis."},{"key":"10.1016\/j.toxicon.2025.108274_bib49","doi-asserted-by":"crossref","first-page":"192","DOI":"10.12688\/f1000research.148223.1","article-title":"Improving in vivo assays in snake venom and antivenom research. A community discussion","volume":"13","author":"Marriott","year":"2024","journal-title":"F1000Res"},{"key":"10.1016\/j.toxicon.2025.108274_bib50","series-title":"The Indian Pharmacopoeia","first-page":"4470","article-title":"Snake venom antiserum","year":"2022"},{"key":"10.1016\/j.toxicon.2025.108274_bib51","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.toxicon.2012.04.342","article-title":"Second generation snake antivenomics: comparing immunoaffinity and immunodepletion protocols","volume":"60","author":"Pl\u00e1","year":"2012","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2025.108274_bib52","doi-asserted-by":"crossref","first-page":"158","DOI":"10.3390\/toxins9050158","article-title":"Third generation antivenomics: pushoing the limits of the in vitro preclinical assessment of antivenoms","volume":"9","author":"Pla","year":"2017","journal-title":"Toxins"},{"key":"10.1016\/j.toxicon.2025.108274_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.toxicon.2013.10.021","article-title":"Development of an in vitro potency assay for antivenom against Malayan pit viper (Calloselasma rhodostoma)","volume":"77","author":"Pornmuttakun","year":"2014","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2025.108274_bib54","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1002\/path.1700390315","article-title":"The estimation of haemorrhagin in venom by an intradermal method and a potency test of antivenomous sera for antihaemorrhagin","volume":"39","author":"Pratt-Johnson","year":"1934","journal-title":"J. Pathol. Bacteriol."},{"key":"10.1016\/j.toxicon.2025.108274_bib55","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0041-0101(66)90063-8","article-title":"Cross neutralization of the coagulant activity of some snake venoms by antivenins","volume":"4","author":"Rosenfeld","year":"1966","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2025.108274_bib56","series-title":"The Principles of Humane Experimental Technique","author":"Russell","year":"1959"},{"key":"10.1016\/j.toxicon.2025.108274_bib57","first-page":"293","article-title":"Problems of antivenin standardization","volume":"5","author":"Sch\u00f6ttler","year":"1952","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.toxicon.2025.108274_bib58","series-title":"Aspectos metodol\u00f3gicos da titula\u00e7\u00e3o de soros antipe\u00e7onhentos","first-page":"249","author":"Sch\u00f6ttler","year":"1954"},{"key":"10.1016\/j.toxicon.2025.108274_bib59","first-page":"73","article-title":"Observa\u00e7\u00f5es miscelaneas sobre pe\u00e7onhas of\u00eddicas e antivenenos","volume":"27","author":"Sch\u00f6ttler","year":"1955","journal-title":"Memorias Instituto Butantan"},{"key":"10.1016\/j.toxicon.2025.108274_bib60","first-page":"2541","article-title":"Antiverino, Suero","volume":"vol. 2","year":"2014"},{"key":"10.1016\/j.toxicon.2025.108274_bib61","article-title":"Design, development and preclinical assessment of MENAVip-ICP, a new snake antivenom with potential coverage of species in the Middle East and North Africa regions","volume":"24","author":"Segura","year":"2024","journal-title":"Toxicon:X"},{"key":"10.1016\/j.toxicon.2025.108274_bib62","first-page":"325","article-title":"Padronica\u00e7\u00e3ao da avalia\u00e7\u00e3o da potencia de antivenenos botr\u00f3picos, em camundongos","volume":"42\/43","author":"Siles Villarroel","year":"1978","journal-title":"Memorias Instituto Butantan"},{"key":"10.1016\/j.toxicon.2025.108274_bib63","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.830384","article-title":"Rodent lethality models are problematic for evaluating antivenoms for human envenoming","volume":"13","author":"Silva","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.toxicon.2025.108274_bib64","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.biologicals.2010.05.006","article-title":"Study of the design and analytical properties of the lethality neutralization assay used to estimate antivenom potency against Bothrops asper snake venom","volume":"38","author":"Solano","year":"2010","journal-title":"Biologicals"},{"key":"10.1016\/j.toxicon.2025.108274_bib65","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.toxicon.2018.05.008","article-title":"The history of antivenoms development: beyond Calmette and Vital Brazil","volume":"150","author":"Squaiella-Baptist\u00e3o","year":"2018","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2025.108274_bib66","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/0041-0101(79)90284-8","article-title":"Enzyme-linked immunosorbent assay (ELISA) in assessing antivenom potency","volume":"17","author":"Theakston","year":"1979","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2025.108274_bib67","first-page":"949","article-title":"Development of simple standard assay procedures for the characterization of snake venom","volume":"61","author":"Theakston","year":"1983","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.toxicon.2025.108274_bib68","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0041-0101(02)00393-8","article-title":"Report of a WHO workshop on the standardization and control of antivenoms","volume":"41","author":"Theakston","year":"2003","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2025.108274_bib69","series-title":"United States Pharmacopeia","first-page":"1","article-title":"Biologics, sec. 1041","year":"2023"},{"key":"10.1016\/j.toxicon.2025.108274_bib70","first-page":"7","article-title":"History of the primordia of snake-bite accident serotherapy","volume":"49","author":"Vital-Brazil","year":"1987","journal-title":"Memorias Instituto Butantan"},{"key":"10.1016\/j.toxicon.2025.108274_bib71","first-page":"1","article-title":"Necrosis, haemorrhage and complement depletion following bites by the spitting cobra (Naja nigricollis)","volume":"45","author":"Warrell","year":"1976","journal-title":"Q. J. Med."},{"key":"10.1016\/j.toxicon.2025.108274_bib72","series-title":"World Health Organization Technical Report Series No. 463","first-page":"20","article-title":"Requirements for snake antivenins","year":"1971"},{"key":"10.1016\/j.toxicon.2025.108274_bib73","first-page":"43","year":"1981"},{"key":"10.1016\/j.toxicon.2025.108274_bib74","first-page":"134","year":"2010"},{"key":"10.1016\/j.toxicon.2025.108274_bib75","series-title":"Annex 5. Replacement of Annex 2 of WHO Technical Report Series No. 964","first-page":"388","article-title":"Guidelines for the production, control and regulation of snake antivenom immunoglobulins","year":"2017"},{"key":"10.1016\/j.toxicon.2025.108274_bib76","series-title":"Target Product Profiles for Animal Plasma-Derived Antivenoms: Antivenoms for Treatment of Snakebite Envenoming in Sub-saharan Africa","first-page":"25","year":"2023"}],"container-title":["Toxicon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041010125000480?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041010125000480?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T17:58:54Z","timestamp":1741024734000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041010125000480"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":76,"alternative-id":["S0041010125000480"],"URL":"https:\/\/doi.org\/10.1016\/j.toxicon.2025.108274","relation":{},"ISSN":["0041-0101"],"issn-type":[{"value":"0041-0101","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The saga of the development of laboratory tests to evaluate the neutralizing efficacy of antivenoms for the treatment of snakebite envenoming","name":"articletitle","label":"Article Title"},{"value":"Toxicon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxicon.2025.108274","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108274"}}